Advances in genomics and epigenetic biomarkers for vulnerability and treatment 
response in mood and anxiety disorders

Binder, E.

Local TagsRelease HistoryDetailsSummary

Advances in genomics and epigenetic biomarkers for vulnerability and treatment response in mood and anxiety disorders

Binder, E. (2014). Advances in genomics and epigenetic biomarkers for vulnerability and treatment response in mood and anxiety disorders. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 17: S-21-002, 24-24.

Item is Released

show all hide all

Basic

show hide

Item Permalink: https://hdl.handle.net/11858/00-001M-0000-0024-C369-7 Version Permalink: https://hdl.handle.net/11858/00-001M-0000-0024-C37C-E

Genre: Meeting Abstract

Files

show Files

Locators

show

Creators

show

hide

Creators:
Binder, E.¹, Author

Affiliations:
1Dept. Translational Research in Psychiatry, Max Planck Institute of Psychiatry, Max Planck Society, ou_2035295

Content

show

Details

show

hide

Language(s): eng - English

Dates: Date issued: 2014-06

Publication Status: Issued

Pages: -

Publishing info: -

Table of Contents: -

Rev. Type: -

Identifiers: ISI: 000339769200095

Degree: -

Event

show

hide

Title: 29th CINP World Congress of Neuropsychopharmacology

Place of Event: Vancouver, CANADA

Start-/End Date: 2014-06-22 - 2014-06-26

Legal Case

show

Project information

show

Source 1

show

hide

Title: INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Source Genre: Journal

Creator(s):

Affiliations:

Publ. Info: New York, NY, USA : Cambridge University Press

Pages: - Volume / Issue: 17 Sequence Number: S-21-002 Start / End Page: 24 - 24 Identifier: ISSN: 1461-1457